Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.

OBJECTIVE To determine the bovine leukemia virus (BLV) antibody response and infectivity status in BLV-vaccinated cattle after challenge exposure with BLV-infected lymphocytes. DESIGN Steers were inoculated with vaccinia virus constructs expressing the gag, pol, and env genes of the BLV or the env gene only of the BLV genome, then challenge exposed with BLV-infected lymphocytes. The steers' BLV antibody and infectivity status was monitored. ANIMALS Fifteen 8- to 9-month-old Holstein steers previously determined to be BLV antibody and BLV negative. PROCEDURE 1 month after second after inoculation, steers were challenge exposed with 10(6) BLV-infected lymphocytes from a highly infective BLV-positive cow. Serum and blood lymphocytes were obtained regularly for 6 months. The agar gel immunodiffusion assay, ELISA, and serum neutralization assay were used to detect BLV antibody in serum of steers. The sheep infectivity and syncytium-forming assays were used to determine the viral status of the steers. RESULTS Differences were seen in antibody responses between the BLV-vaccinated and non-BLV-vaccinated control groups. All cattle were susceptible to infection when challenge exposed with BLV-infected lymphocytes. CONCLUSION Despite the enhanced immune response in the BLV-vaccinated cattle after challenge exposure, none of the BLV-vaccinated cattle was protected from BLV infection. CLINICAL RELEVANCE Vaccination is not an effective way to protect cattle from BLV infection.

• Publication year

  1996

• Venue

  American Journal of Veterinary Research

• Publication date

  1996-06-01

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology

• Identifiers
  DOI 10.2460/ajvr.1996.57.06.812PMID 8725805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70

  1993cited by this paper
• Involvement of CD8+ T Cells in Delayed-type Hypersensitivity Responses against Bovine Leukemia Virus (BLV) Induced in Sheep Vaccinated with Recombinant Vaccinia Virus Expressing BLV Envelope Glycoprotein

  1993cited by this paper
• Augmentation of Bovine Leukemia Virus (BLV)‐Specific Lymphocyte Proliferation Responses in Ruminants by Inoculation with BLV env‐Recombinant Vaccinia Virus: Their Role in the Suppression of BLV Replication

  1992cited by this paper
• Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells.

  1992cited by this paper
• Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression

  1992cited by this paper
• Characterization of purified gp 51 from bovine leukemia virus integrated into iscom

  1991cited by this paper
• Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.

  1991cited by this paper
• Factors associated with in utero or periparturient transmission of bovine leukemia virus in calves on a California dairy.

  1991cited by this paper
• Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.

  1991cited by this paper
• Transfer of immunoglobulins and survival of newborn calves.

  1991cited by this paper
• Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.

  1990cited by this paper
• Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.

  1989cited by this paper
• Protection of colostral antibodies against bovine leukemia virus infection in calves on a California dairy.

  1989cited by this paper
• Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.

  1989cited by this paper
• An ELISA for the diagnosis of bovine leukaemia virus infection

  1988cited by this paper
• Protection against bovine leukemia virus infection in sheep by active and passive immunization.

  1986cited by this paper
• Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.

  1984cited by this paper
• Establishment of a bovine leukosis virus-free dairy herd.

  1984cited by this paper
• Factors affecting the infectivity of lymphocytes from cattle with bovine leukosis virus.

  1984cited by this paper
• The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV.

  1983cited by this paper
• Use of monoclonal antibody in an ELISA test for the detection of antibodies to bovine leukaemia virus.

  1983cited by this paper
• Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.

  1982cited by this paper
• Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.

  1982cited by this paper
• Fall in antibody titer to bovine leukemia virus in the periparturient period.

  1982cited by this paper
• Duration of colostral antibodies to bovine leukemia virus by two serologic tests.

  1982cited by this paper
• Optimum conditions for the radioimmunoprecipitation assay for the major internal protein of bovine leukemia virus.

  1981cited by this paper
• Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species

  1981cited by this paper
• Effect of colostral antibody on bovine leukemia virus infection of neonatal calves.

  1981cited by this paper
• In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety.

  1980cited by this paper
• Use of a continuous feline cell line for virologic and serologic investigations of bovine leukemia virus infections.

  1980cited by this paper
• An infectivity assay for bovine leukemia virus using the immunoperoxidase technique.

  1979cited by this paper
• Immunologic methods for the detection of humoral and cellular immunity.

  1978cited by this paper
• Induction of syncytia by the bovine C-type leukemia virus.

  1976cited by this paper

• The Global Epidemiology of Bovine Leukemia Virus: Current Trends and Future Implications

  2024cites this paper
• Expression, Purification, and Characterization of Bovine Leukemia Virus-Like Particles Produced in Drosophila S2 Cells

  2021cites this paper
• Seroprevalence of bovine leukosis infection in selected farming systems in Kenya

  2018cites this paper
• Dinámica de infección con el virus de la leucosis bovina en bovinos holando argentino portadores de genotipos definidos del gen bola drb3

  2018cites this paper
• Bovine leukemia virus: current perspectives

  2017cites this paper
• Bovine leukemia virus: current perspectives

  2017cites this paper
• Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV

  2011cites this paper
• Epidemiology, infection dynamics and effective control of Bovine Leukemia virus within dairy herds of Argentina: a quantitative approach

  2005cites this paper
• γδ+ T-Lymphocyte Cytotoxicity against Envelope-Expressing Target Cells Is Unique to the Alymphocytic State of Bovine Leukemia Virus Infection in the Natural Host

  2000cites this paper
• Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.

  1999cites this paper